Xiangxi Wang

15.7k citations
71 papers · 3.7k · 2 hit papers · h-index 27

Impact in

Papers in

Xiangxi Wang

69 papers receiving 3.7k citations

Xiangxi Wang's Hit Papers

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial 2020 · 956 citations
9560+2+4Years since publication250500750

Peers

Xiangxi Wang
Comparison fields: 5 of 132
  • Infectious Diseases 1.8k
  • Cardiology and Cardiovascular Medicine 1.0k
  • Agronomy and Crop Science 460
  • Health 220
  • Structural Biology 40
Replace Junzhi Wang with:
Junzhi Wang China
Leyi Wang United States
Gideon Kersten Netherlands
Klaus Überla Germany
Tadaki Suzuki Japan
Yanbing Li China
Nanping Wu China
Jinxia Zhang China
Christiane E. Wobus United States
Xiangxi Wang relative to Junzhi Wang China Junzhi Wang's profile →
Citations per field
00.5×2.7×
Junzhi Wang · 1×
Citations per year

Countries citing papers authored by Xiangxi Wang

Since Specialization
Citations

This map shows the geographic impact of Xiangxi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangxi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangxi Wang more than expected).

Fields of papers citing papers by Xiangxi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangxi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangxi Wang. The network helps show where Xiangxi Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiangxi Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiangxi Wang Line = papers co-authored together Xiangxi Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
Hit paper breakdown →
2020956
2 2012328
3
Architecture of African swine fever virus and implications for viral assembly
Hit paper breakdown →
2019323
4 2020272
5 2014135
6 2021130
7 2013126
8 2017121
9 201492
10 201889
11 201882
12 201477
13 201877
14 201961
15 201551
16 202047
17 201845
18 201544
19 202143
20 201542

About Xiangxi Wang

Xiangxi Wang is a scholar working on Infectious Diseases, Cardiology and Cardiovascular Medicine, Molecular Biology, Epidemiology and Biomedical Engineering, having authored 71 papers that have together received 3.7k indexed citations. Recurring topics across this work include Viral Infections and Immunology Research (25 papers), Viral gastroenteritis research and epidemiology (16 papers), SARS-CoV-2 and COVID-19 Research (11 papers), RNA and protein synthesis mechanisms (11 papers), Cytomegalovirus and herpesvirus research (9 papers), Animal Virus Infections Studies (7 papers), Viral Infections and Vectors (7 papers) and Animal Disease Management and Epidemiology (6 papers). The work is most often cited by research in Infectious Diseases (1.8k citations), Cardiology and Cardiovascular Medicine (1.0k citations), Agronomy and Crop Science (460 citations), Health (220 citations) and Structural Biology (40 citations). Xiangxi Wang has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Zihe Rao, Weidong Yin, Junzhi Wang, David I. Stuart, Elizabeth E. Fry, Jingshan Ren, Minnan Yang, Zhongyu Hu, Yanjun Zhang and Fengcai Zhu. Their work appears in journals such as Nature Communications, Protein & Cell, Journal of Virology, Proceedings of the National Academy of Sciences and Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact